China’s biotech industry sees global expansion as unstoppable, despite US pressure

AI Summary

China's biotech sector is expanding globally despite facing US regulatory barriers and national security measures. The industry views this growth as unstoppable even amid geopolitical tensions.

China’s biotech firms are pressing ahead with global expansion, a trend industry insiders describe as “irreversible”, even as Washington rolls out investment restrictions and national security measures aimed at slowing their advance. “The US has erected numerous regulatory and non-tariff barriers for Chinese companies seeking to enter the American market,” said Zhang Jun, co-head of the global healthcare group at Chinese investment bank Citic Securities, at the Hong Kong Exchanges and Clearing’s...